Trial
NCT05030623
The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Sadat City University
Collaborators
—
Condition
Major Depressive Disorder
Intervention
Tadalafil 5Mg Tab
Why stopped
Institutional and funding constrains
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-14